Morphogenesis of Lewy Bodies: Dissimilar Incorporation of α-Synuclein, Ubiquitin, and p62

Journal of Neuropathology and Experimental Neurology

Volumn 62, Issue 12, 2003, Pages 1241-1253

  Kuusisto, Erkki ^a,b   Parkkinen, Laura ^a   Alafuzoff, Irina ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Aggresome; Cytoplasmic inclusion; Pale body; Parkinson disease; Protein aggregation; Substantia nigra

Indexed keywords

ALPHA SYNUCLEIN; PROTEIN P62; UBIQUITIN;

ADULT; AGED; ARTICLE; CELL STRUCTURE; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LEWY BODY; LIVER CELL; MALE; NEUROPATHOLOGY; PARKINSON DISEASE; PERIKARYON; PRIORITY JOURNAL; PROTEIN AGGREGATION; SUBSTANTIA NIGRA;

EID: 0344305371     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/62.12.1241     Document Type: Article

References (48)

1. Lowe J, Lennox G, Leigh PN. Disorders of movement and system degenerations. In: Graham DI, Lantos PL, eds. Greenfield's Neuropathology. London: Arnold, 1997:281-366
2. Pollanen MS, Dickson DW, Bergeron C. Pathology and biology of the Lewy body. J Neuropathol Exp Neurol 1993;52:183-91
3. Gibb WR, Scott T, Lees AJ. Neuronal inclusions of Parkinson's disease. Mov Disord 1991;6:2-11
4. Lotharius J, Brundin P. Pathogenesis of Parkinson's disease: Dopamine, vesicles and α-synuclein. Nat Rev Neurosci 2002;3:932-42
5. Dale GE, Probst A, Luthert P. Martin J, Anderton BH, Leigh PN. Relationships between Lewy bodies and pale bodies in Parkinson's disease. Acta Neuropathol (Berl) 1992;83:525-29
6. Forno LS. Neuropathology of Parkinson's disease. J Neuropathol Exp Neurol 1996;55:259-72
7. Pappolla MA. Lewy bodies of Parkinson's disease. Immune electron microscopic demonstration of neurofilament antigens in constituent filaments. Arch Pathol Lab Med 1986;110:1160-63
8. Pappolla MA, Shank DL, Alzofon J, Dudley AW. Colloid (hyaline) inclusion bodies in the central nervous system: Their presence in the substantia nigra is diagnostic of Parkinson's disease. Hum Pathol 1988;19:27-31
9. Roy S, Wolman L. Ultrastructural observations in parkinsonism. J Pathol 1969;99:39-44
10. Gomez-Tortosa E, Newell K, Irizarry MC, Sanders JL, Hyman BT. α-Synuclein immunoreactivity in dementia with Lewy bodies: Morphological staging and comparison with ubiquitin immunostaining. Acta Neuropathol (Berl) 2000;99:352-57
11. Wakabayashi K, Hayashi S, Kakita A, et al. Accumulation of α-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy. Acta Neuropathol (Berl) 1998;96:445-52
12. Alves-Rodrigues A, Gregori L, Figueiredo-Pereira ME. Ubiquitin, cellular inclusions and their role in neurodegeneration. Trends Neurosci 1998;21:516-20
13. Kitada T, Asakawa S, Hattori N, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998;392:605-8
14. Leroy E, Boyer R, Auburger G, et al. The ubiquitin pathway in Parkinson's disease. Nature 1998;395:451-52
15. McNaught KS, Jenner P. Proteasomal function is impaired in substantia nigra in Parkinson's disease. Neurosci Lett 2001;297:191-94
16. McNaught KS, Bjorklund LM, Belizaire R, Isacson O, Jenner P, Olanow CW. Proteasome inhibition causes nigral degeneration with inclusion bodies in rats. Neuroreport 2002;13:1437-41
17. Kuusisto E, Salminen A, Alafuzoff I. Ubiquitin-binding protein p62 is present in neuronal and glial inclusions in human tauopathies and synucleinopathies. NeuroReport 2001;12:2085-90
18. Stumptner C, Fuchsbichler A, Heid H, Zatloukal K, Denk H. Mallory body-a disease-associated type of sequestosome. Hepatology 2002;35:1053-62
19. Chang S, Kim JH, Shin J. p62 forms a ternary complex with PKCζ and PAR-4 and antagonizes PAR-4-induced PKCζ inhibition. FEBS Lett 2002;510:57-61
20. Wooten MW, Seibenhener ML, Mamidipudi V, Diaz-Meco MT, Barker PA, Moscat J. The atypical protein kinase C-interacting protein p62 is a scaffold for NF-κB activation by nerve growth factor. J Biol Chem 2001;276:7709-12
21. Gong J, Xu J, Bezanilla M, van Huizen R, Derin R, Li M. Differential stimulation of PKC phosphorylation of potassium channels by ZIP1 and ZIP2. Science 1999;285:1565-69
22. Kuusisto E, Salminen A, Alafuzoff I. Early accumulation of p62 in neurofibrillary tangles in Alzheimer's disease: Possible role in tangle formation. Neuropathol Appl Neurobiol 2002;28:228-37
23. Parkkinen L, Soininen H, Alafuzoff I. Regional distribution of α-synuclein pathology in unimpaired aging and in Alzheimer's disease. J Neuropathol Exp Neurol 2003;62:363-67
24. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 1991;82:239-59
25. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-86
26. Iseki E, Marui W, Akiyama H, Ueda K, Kosaka K. Degeneration process of Lewy bodies in the brains of patients with dementia with Lewy bodies using α-synuclein-immunohistochemistry. Neurosci Lett 2000;286:69-73
27. Fujigasaki H, Uchihara T, Takahashi J, et al. Preferential recruitment of ataxin-3 independent of expanded polyglutamine: An immunohistochemical study on Marinesco bodies. J Neurol Neurosurg Psychiatry 2001;71:518-20
28. Bancher C, Lassmann H, Budka H, et al. An antigenic profile of Lewy bodies: Immunocytochemical indication for protein phosphorylation and ubiquitination. J Neuropathol Exp Neurol 1989;48:81-93
29. Baba M, Nakajo S, Tu PH, et al. Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 1998;152:879-84
30. Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M. α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc Natl Acad Sci U S A 1998;95:6469-73
31. Braak E, Sandmann-Keil D, Rub U, et al. α-Synuclein immunopositive Parkinson's disease-related inclusion bodies in lower brain stem nuclei. Acta Neuropathol (Berl) 2001;101:195-201
32. Lee HJ, Lee SJ. Characterization of cytoplasmic α-synuclein aggregates. Fibril formation is tightly linked to the inclusion-forming process in cells. J Biol Chem 2002;277:48976-83
33. Lee HJ, Shin SY, Choi C, Lee YH, Lee SJ. Formation and removal of α-synuclein aggregates in cells exposed to mitochondrial inhibitors. J Biol Chem 2002;277:5411-17
34. Jakes R, Crowther RA, Lee VM, Trojanowski JQ, Iwatsubo T, Goedert M. Epitope mapping of LB509, a monoclonal antibody directed against human α-synuclein. Neurosci Lett 1999;269:13-16
35. Fujiwara H, Hasegawa M, Dohmae N, et al. α-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 2002;4:160-64
36. Ellis CE, Schwartzberg PL, Grider TL, Fink DW, Nussbaum RL. α-Synuclein is phosphorylated by members of the Src family of protein-tyrosine kinases. J Biol Chem 2001;276:3879-84
37. Crowther RA, Jakes R, Spillantini MG, Goedert M. Synthetic filaments assembled from C-terminally truncated α-synuclein. FEBS Lett 1998;436:309-12
38. Takahashi H, Iwanaga K, Egawa S, Ikuta F. Ultrastructural relationship between Lewy bodies and pale bodies studied in locus ceruleus neurons of a non-parkinsonian patient. Neuropathology 1994;14:73-80
39. Geetha T, Wooten MW. Structure and functional properties of the ubiquitin binding protein p62. FEBS Lett 2002;512:19-24
40. Wakabayashi K, Engelender S, Tanaka Y, et al. Immunocytochemical localization of synphilin-1, an α-synuclein-associated protein, in neurodegenerative disorders. Acta Neuropathol (Berl) 2002;103:209-14
41. Denk H, Stumptner C, Zatloukal K. Mallory bodies revisited. J Hepatol 2000;32:689-702
42. Zatloukal K, Stumptner C, Fuchsbichler A, et al. p62 is a common component of cytoplasmic inclusions in protein aggregation diseases. Am J Pathol 2002;160:255-63
43. Zatloukal K, Stumptner C, Lehner M, et al. Cytokeratin 8 protects from hepatotoxicity, and its ratio to cytokeratin 18 determines the ability of hepatocytes to form Mallory bodies. Am J Pathol 2000;156:1263-74
44. Riley NE, Li J, Worrall S, et al. The Mallory body as an aggresome: In vitro studies. Exp Mol Pathol 2002;72:17-23
45. McNaught KS, Shashidharan P, Perl DP, Jenner P, Olanow CW. Aggresome-related biogenesis of Lewy bodies. Eur J Neurosci 2002;16:2136-48
46. Johnston JA, Ward CL, Kopito RR. Aggresomes: A cellular response to misfolded proteins. J Cell Biol 1998;143:1883-98
47. Wigley WC, Fabunmi RP, Lee MG, et al. Dynamic association of proteasomal machinery with the centrosome. J Cell Biol 1999;145:481-90
48. Garcia-Mata R, Bebok Z, Sorscher EJ, Sztul ES. Characterization and dynamics of aggresome formation by a cytosolic GFP-chimera. J Cell Biol 1999;146:1239-54